Estradiol

Estradiol is the most potent endogenous estrogen, and Ray Peat consistently framed it not as a benign female hormone but as a fundamental stress hormone and carcinogen that rises with aging, hypothyroidism, and tissue injury. 3 Its potency is relative: estradiol is considered about 10 times as active as estrone and 3 to 4 times as active as estriol, though all are interchangeable at different doses and share harmful effects if exposure is continuous. 2 Peat emphasized that the common practice of measuring estradiol in serum is misleading because these oil-soluble steroids accumulate inside cells, meaning tissue exposure can be high even when blood levels appear low, especially in aging individuals with declining progesterone. 2

The production and retention of estradiol are regulated by multiple enzymes and systemic factors. The aromatase enzyme synthesizes estrogen from androgens in tissues throughout the body—including fat, skin, breast, and brain—and its activity increases with aging and under the influence of prolactin, cortisol, and FSH. 1 Once formed, estradiol is inactivated in the liver by conjugation with glucuronic acid, but the enzyme beta-glucuronidase in inflamed tissues can cleave this conjugate, releasing pure active estrogen to accumulate locally. 1 Hypothyroidism and dietary protein deficiency both impair the liver's ability to detoxify estrogen, creating a vicious cycle where retained estrogen further suppresses thyroid function. 2 Georgi Dinkov has added that estradiol is the declared tumor carcinogen by both the CDC and WHO, and that even estrone, its precursor, signals high aromatase activity and poor prognosis. 7

Peat described estradiol's cellular effects as fundamentally tied to energy failure. It acts as an excitotoxin, initially increasing alertness by potentiating adrenaline, but chronically it disrupts mitochondrial electron transfer through futile redox cycling, lowering the metabolic rate and shifting energy production toward lactic acid instead of carbon dioxide. 2 This metabolic disruption causes cells to take up water and calcium, increases vascular leakiness via serotonin and histamine, and can lead to conditions ranging from edema and varicose veins to calciphylaxis and scleroderma. 2 Dinkov has cited studies showing that estradiol administration dramatically increases prostate tumor growth, while DHT can cause tumors to disappear, directly contradicting the androgen hypothesis of prostate cancer. 5

Progesterone functions as a comprehensive anti-estrogen, acting through roughly ten distinct mechanisms: it suppresses aromatase, activates enzymes that eliminate estrogen, and directly destroys the estrogen receptor protein. 2 Peat noted that progesterone can mobilize estradiol out of tissues in a detoxified form, making it measurable in blood again, which explains why postmenopausal women with low serum estradiol may actually have high tissue burdens. 2 Weaker estrogens like estriol or 17-alpha-estradiol can act as competitive antagonists at the receptor when powerful estradiol is present, but Peat cautioned that estriol is not protective—its elevated conversion from estradiol is a consequence of disease, not a cause of protection, and it concentrates in hormone-dependent tumors. 2 Even phytoestrogens, while sometimes anti-inflammatory, can be either pro- or anti-estrogenic depending on context. 2 The fundamental protective strategy Peat advocated was maintaining thyroid function, protein and B-vitamin intake, and progesterone levels to keep estradiol production and tissue accumulation in check. 2